Combination therapies: a journey into personalized vaccine immunotherapeutics for early-stage cancers

Immuno-Oncology Insights 2024; 5(2), 35–40

DOI: 10.18609/IOI.2024.006

Published: 6 March
Stephen Johnston

Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Stephen Johnston, CEO, Calviri, about the shift in the I-O space to preventative treatment in combination for early­-stage cancers.